Belite Bio Inc Adr (BLTE)

Oct 06, 2026

Belite Bio CMO Scholl sells $82,658 in shares By Investing.com - Investing.com South Africa

Oct 06, 2026

Oct 05, 2026

Form 4 Belite Bio Inc ADR For: 5 October By Investing.com - Investing.com UK

Oct 05, 2026

Oct 05, 2026

Belite Bio CMO Scholl sells $82,658 in shares - Investing.com

Oct 05, 2026

Oct 01, 2026

4,000 Belite Bio (BLTE) depositary shares are proposed for sale, valued at $679K. - Stock Titan

Oct 01, 2026

Sep 30, 2026

Belite Bio (BLTE) Climbs 1.97% to $169.94 as Shares Hold Above Key SupportValue Area High - https://www.siam.in/

Sep 30, 2026

Sep 17, 2026

Belite Bio, IncAmerican Depositary Shares (Nasdaq:BLTE) Detailed Stock Data - The Chronicle-Journal

Sep 17, 2026

Sep 11, 2026

Belite Bio at Cantor healthcare conference: tinlarebant advances - Investing.com India

Sep 11, 2026

Sep 11, 2026

Belite Bio at Cantor healthcare conference: tinlarebant advances By Investing.com - Investing.com Canada

Sep 11, 2026

Sep 10, 2026

Belite Bio CFO Chuang Hao-Yuan sells $12.8 million in company ADSs By Investing.com - Investing.com South Africa

Sep 10, 2026

Sep 10, 2026

Wednesday’s top insider buys and sells: NVIDIA leads activity By Investing.com - Investing.com Australia

Sep 10, 2026

Sep 10, 2026

Wednesday’s top insider buys and sells: NVIDIA leads activity By Investing.com - Investing.com India

Sep 10, 2026

Sep 10, 2026

Wednesday’s top insider buys and sells: NVIDIA leads activity - Investing.com

Sep 10, 2026

Sep 09, 2026

Belite Bio CFO Chuang Hao-Yuan sells $12.8 million in company ADSs - Investing.com

Sep 09, 2026

Sep 09, 2026

Belite Bio CEO Lin Yu-Hsin sells $19.08m in company shares - Investing.com

Sep 09, 2026

Sep 09, 2026

Belite Bio CFO Chuang Hao-Yuan sells $12.8 million in company ADSs - Investing.com India

Sep 09, 2026

Sep 09, 2026

Belite Bio CFO Chuang Hao-Yuan sells $12.8 million in company ADSs - Investing.com Nigeria

Sep 09, 2026

Sep 09, 2026

Belite Bio CEO Lin Yu-Hsin sells $19.08m in company shares - Investing.com Canada

Sep 09, 2026

Sep 09, 2026

Belite Bio CEO Lin Yu-Hsin sells $19.08m in company shares - Investing.com UK

Sep 09, 2026

Sep 09, 2026

How Belite Bio Inc (BLTE) Affects Rotational Strategy Timing - Stock Traders Daily

Sep 09, 2026

Sep 09, 2026

Belite Bio stock price target raised to $245 by H.C. Wainwright on Japan NDA filing - Investing.com Nigeria

Sep 09, 2026

Sep 09, 2026

Belite Bio stock price target raised to $245 by H.C. Wainwright on Japan NDA filing - Investing.com Australia

Sep 09, 2026

Sep 09, 2026

Mizuho raises Belite Bio stock price target on Japan drug filing - Investing.com Australia

Sep 09, 2026

Sep 09, 2026

Mizuho raises Belite Bio stock price target on Japan drug filing - Investing.com Nigeria

Sep 09, 2026

Sep 09, 2026

Belite Bio, Inc. Sponsored ADR (BLTE)'s Technical Outlook is Bright After Key Golden Cross - Yahoo Finance

Sep 09, 2026

Sep 09, 2026

Belite Bio, Inc. Sponsored ADR (BLTE)'s Technical Outlook is Bright After Key Golden Cross - Zacks Investment Research

Sep 09, 2026

Sep 09, 2026

Belite Bio stock price target raised to $245 by H.C. Wainwright on Japan NDA filing - investing.com

Sep 09, 2026

Sep 09, 2026

Belite Bio stock price target raised to $245 by H.C. Wainwright on Japan NDA filing - Investing.com UK

Sep 09, 2026

Sep 09, 2026

Belite Bio stock price target raised to $245 by H.C. Wainwright on Japan NDA filing - Investing.com

Sep 09, 2026

Sep 09, 2026

Mizuho raises Belite Bio stock price target on Japan drug filing - Investing.com

Sep 09, 2026

Sep 09, 2026

Mizuho raises Belite Bio stock price target on Japan drug filing By Investing.com - Investing.com South Africa

Sep 09, 2026

Sep 08, 2026

Belite Bio at Wells Fargo conference: nda review lifts stakes By Investing.com - Investing.com Canada

Sep 08, 2026

Sep 08, 2026

Belite Bio at Wells Fargo conference: nda review lifts stakes By Investing.com - Investing.com UK

Sep 08, 2026

Sep 08, 2026

Belite Bio files Japan NDA for Stargardt disease drug - grafa.com

Sep 08, 2026

Sep 08, 2026

Belite Bio submits drug application in Japan for Stargardt disease By Investing.com - Investing.com Nigeria

Sep 08, 2026

Sep 08, 2026

Belite Bio submits drug application in Japan for Stargardt disease By Investing.com - Investing.com South Africa

Sep 08, 2026

Sep 08, 2026

Belite Bio Files Sakigake-Backed Tinlarebant NDA in Japan for Stargardt Disease - TipRanks

Sep 08, 2026

Sep 08, 2026

Belite Bio Announces Submission of New Drug Application to the Ministry of Health, Labour, and Welfare in Japan under the Sakigake Designation System for Tinlarebant for the Treatment of Stargardt... - markets.businessinsider.com

Sep 08, 2026

Sep 08, 2026

Belite Bio submits drug application in Japan for Stargardt disease By Investing.com - Investing.com Canada

Sep 08, 2026

Sep 08, 2026

Belite Bio submits drug application in Japan for Stargardt disease - investing.com

Sep 08, 2026

Sep 08, 2026

Belite Bio (NASDAQ: BLTE) seeks Japan OK for Stargardt pill that could be a first - Stock Titan

Sep 08, 2026

Sep 04, 2026

Canaccord initiates Belite Bio stock with buy on Stargardt therapy By Investing.com - Investing.com South Africa

Sep 04, 2026

Sep 04, 2026

Belite Bio Pops As Wall Street Backs Stargardt Bet - TipRanks

Sep 04, 2026

Sep 04, 2026

Canaccord initiates Belite Bio stock with buy on Stargardt therapy By Investing.com - Investing.com Nigeria

Sep 04, 2026

Sep 04, 2026

Canaccord initiates Belite Bio stock with buy on Stargardt therapy - investing.com

Sep 04, 2026

Sep 04, 2026

Canaccord initiates Belite Bio stock with buy on Stargardt therapy By Investing.com - Investing.com UK

Sep 04, 2026

Sep 03, 2026

Belite Bio Surges As Tinlarebant Nears FDA Decision - TipRanks

Sep 03, 2026

Sep 03, 2026

H.C. Wainwright reiterates Belite Bio stock rating on commercial plans By Investing.com - Investing.com Australia

Sep 03, 2026

Sep 03, 2026

H.C. Wainwright reiterates Belite Bio stock rating on commercial plans - Investing.com

Sep 03, 2026

Sep 03, 2026

H.C. Wainwright reiterates Belite Bio stock rating on commercial plans By Investing.com - Investing.com India

Sep 03, 2026

Sep 03, 2026

H.C. Wainwright reiterates Belite Bio stock rating on commercial plans By Investing.com - Investing.com Canada

Sep 03, 2026